Le Lézard
Classified in: Health, Science and technology
Subject: NEW PRODUCTS/SERVICES

Biosenta Announces Record Revenues


CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360. The Purchase Order is for an initial order of 145 drums (30,160 litres) of TRUE disinfectant and continued monthly orders.

This marks a milestone for Biosenta of achieving record revenues as it continues to implement its strategic plan to position the company to be a leader in the growing disinfectant market in North America. The agreement with SANITIZATION 360 is a perfect fit for Biosenta's growth plans and aligns itself with a company that sells leading edge disinfectants products.

About SANITIZATION 360

SANITIZATION 360 is a Canadian sanitization and disinfectant company with leading-edge products to combat viruses and bacteria.

About Biosenta

Biosenta develops and manufactures a range of wet and dry anti-microbial chemical compounds for household and industrial applications using active material, and advanced encapsulated nanotechnology.

Disclaimer

In no way, the CSE has passed upon the contents of this news release and further has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the CSE) accepts responsibility for this release's adequacy or accuracy.

Biosenta Digital channel:

https://www.Biosenta.com

Contact Information:

Am Gill
President and CEO
T: 416-410-2019

For further information on the project,
please contact: 

Sales
Biosenta Inc.
34 Wrangler Place, Suite 10
Rocky View County, Alberta T1X 0L7
T: 416-410-2019
E: [email protected]
     For Investor Relations, 
please contact: 

Investor Relations
Biosenta Inc.
18 Wynford Drive, Suite 704
Toronto, Ontario M3C 3S2
T: 416-410-2019
E: [email protected]
   


These press releases may also interest you

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:50
Cantaloupe, Inc. , a leading provider of end-to-end technology solutions for self-service commerce, today announced that management will host a webcast to discuss its financial results for the third quarter of fiscal year 2024 on Thursday, May 9,...

at 17:31
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

at 17:21
Tri Ri Asset Management ("TRAM") is pleased to announce a strategic investment from its flagship venture capital fund, the TRAM Venture Fund ("TRAM VF"), in OUNO, a pioneering executive ride-hailing platform headquartered in London. This...

at 17:20
Melanie McFaddin, representative of Wiley Bros ? Aintree Capital &Partners, LLC ("WBAC") is pleased to announce its representation of Theoris, Inc. ("Theoris" and the "Company") in its sale to CoreTech Consulting Group, LLC ("CoreTech"). Theoris'...

at 17:16
Moore Law, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against: Sharecare...



News published on and distributed by: